Profile picture

Professor Erland Erdmann

University of Cologne, Cologne (Germany)
Membership: FESC Member
Follow
Biography
From 1993 until 2012 I served as head of the university heart center Cologne. My main scientific interests are pathophysiology and treatment options of heart failure as well as the role of diabetes in cardiovascular disease. I have served in the steering committees of several major international drug and device trials directed to improve cardiovascular diseases such as CIBIS I, II and III, CARE-HF, PROACTIVE, SERVE-HF (all of which have been published in NEJM or The Lancet). Until 2025 I was editor of the main German textbook of cardiology (Klinische Kardiologie) 2024 in the 9th edition. Together with Nikolaus Marx/Aachen University this German Textbook was published 2025 as Clinical Cardiology, 2nd edition by Springer-Nature. Furthermore I serve in the ethics committee of the medical faculty of the University of Cologne/Germany.
Logo ESC

Contributor content

Cinaciguat, a soluble guanylate cyclase activator, unloads the heart but also causes hypotension in acute decompensated heart failure<sup> </sup>
Journal
Cinaciguat, a soluble guanylate cyclase activator, unloads the heart but also causes hypotension in acute decompensated heart failure<sup> </sup>
9 July 2012
Safety and tolerability of beta-blockers: prejudices and reality
Journal
Safety and tolerability of beta-blockers: prejudices and reality
1 March 2009
Weighing up the cardiovascular benefits of thiazolidinedione therapy: the impact of increased risk of heart failure
Journal
Weighing up the cardiovascular benefits of thiazolidinedione therapy: the impact of increased risk of heart failure
1 January 2008